The Malignant Pleural Effusion Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Malignant Pleural Effusion Market?
The size of the malignant pleural effusion market has expanded significantly over the years. The market, which stood at $4.42 billion in 2024, is predicted to increase to $4.74 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Malignant Pleural Effusion Industry?
The market size for the malignant pleural effusion is projected to reach $6.17 billion in 2029, with a compound annual growth rate (CAGR) of 6.8%.
Download Your Free Sample of the 2025 Malignant Pleural Effusion Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Malignant Pleural Effusion Market?
The key drivers in the malignant pleural effusion market are:
• Enhancement of healthcare infrastructure
• Rising support from government authorities
• Growth in the number of cancer survivors
• Growing demand for home-based care services
Global Market Segmentation: Identifying Major Malignant Pleural Effusion Industry Segments
The malignant pleural effusion market covered in this report is segmented –
1) By Treatment: Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter
2) By Diagnosis: Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy
3) By End Users: Hospitals, Ambulatory Clinics, Other End Users
Subsegments:
1) By Systemic Therapy: Chemotherapy, Targeted Therapy, Immunotherapy
2) By Therapeutic Thoracentesis: Single-Time Thoracentesis, Repeated Thoracentesis
3) By Thoracic Drainage And Pleurodesis:Chemical Pleurodesis, Mechanical Pleurodesis, Biological Pleurodesis
4) By Indwelling Pleural Catheter:Tunneled Pleural Catheter, Non-Tunneled Pleural Catheter
Pre-order the 2025 Malignant Pleural Effusion Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Malignant Pleural Effusion Market?
The key trends in the malignant pleural effusion market are:
• The integration of artificial intelligence in imaging tools is a prominent emerging trend.
• Advances in targeted cancer therapies significantly shape the market.
• There is a noticeable trend towards advancements in pleurodesis.
• Increasing clinical trials for novel therapeutic agents is another key trend.
Who Are the Top Competitors & Leading Players in the Malignant Pleural Effusion Market?
Major players in the malignant pleural effusion market are:
• Pfizer Inc.
• Merck & Co. Inc.
• Novartis International AG
• Bristol-Myers Squibb Company
• Gilead Sciences Inc.
• Amgen Inc.
• Medline Industries LP
• Becton Dickinson and Company
• Cook Medical LLC
• Merit Medical Systems Inc.
• Argon Medical Devices Inc.
• B Braun SE
• Simcere Pharmaceutical Group Limited
• pfm medical AG
• Redax SpA
• Wuhan YZY Biopharma Co. Ltd.
• Rocket Medical plc
• Genelux Corporation
• Gongwin Biopharm Holdings Co. Ltd.
• Ewimed GmbH
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the malignant pleural effusion market in 2024
